About
Novo Nordisk explores how quantum computing could support pharmaceutical research and drug discovery. Its work investigates quantum algorithms for molecular simulation, protein folding prediction, and drug optimization that could speed up the development of diabetes and obesity treatments. The company also researches quantum machine learning for analyzing clinical trial data, patient stratification, and personalized medicine, looking at how quantum computing could strengthen pharmaceutical research in endocrinology and metabolic disease. To do this, Novo Nordisk works with quantum computing companies and academic institutions on computational chemistry, biomarker discovery, and therapeutic development, contributing to the pharmaceutical industry's wider adoption of quantum technologies for diabetes care and chronic disease management.
Quantum Specifications
| Quantum Focus | software |